Indian equity markets are set to open on a positive note on Monday, August 25, 2025, tracking strong global cues after US Federal Reserve Chair Jerome Powell hinted at a potential interest rate cut. Several key companies, including Reliance Industries, IndiGo, Max Healthcare, Yes Bank, and IDBI Bank, will remain in focus during today’s trading session.
Indian stock markets are expected to begin the week on a stronger footing, supported by global momentum. At 7:56 AM, GIFT Nifty futures traded at 24,955, up 57 points, signaling a likely positive opening for benchmark indices.
Across the Asia-Pacific region, markets reflected the optimism seen on Wall Street, where the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite closed sharply higher. The gains were triggered after US Federal Reserve Chair Jerome Powell, speaking at the Jackson Hole Symposium in Wyoming, indicated that an interest rate cut could be considered as early as next month.
Asian markets followed suit: Japan’s Nikkei 225 advanced 1.08%, South Korea’s Kospi rose 0.75%, Australia’s S&P/ASX 200 gained 0.87%, while China’s Shanghai Composite moved up 0.64%. Investors also await Singapore’s Consumer Price Index (CPI) data for July to gauge regional inflation trends.
Stocks to Watch Today
- Nifty50 Rejig:
InterGlobe Aviation (IndiGo) and Max Healthcare Institute are set to replace Hero MotoCorp and IndusInd Bank in the Nifty 50 index, effective September 30, 2025. The reshuffle positions aviation and healthcare as growing segments in the benchmark index.
- Yes Bank:
Sumitomo Mitsui Banking Corporation (SMBC) has received approval from the Reserve Bank of India (RBI) to acquire up to 24.99% equity stake in Yes Bank. The approval is valid for one year, though RBI clarified that SMBC will not be classified as a promoter. This move could strengthen Yes Bank’s capital base and enhance global strategic partnerships.
- Reliance Industries (RIL):
Mumbai-headquartered Reliance Industries Limited (RIL) announced that its step-down wholly owned subsidiary, Nauyaan Tradings Private Limited (NTPL), has acquired the remaining 6.1% equity in Nauyaan Shipyard Private Limited (NSPL) from Welspun Corp for ₹45.32 crore. With this acquisition, NSPL becomes a full step-down subsidiary, further expanding RIL’s presence in shipbuilding and infrastructure.
- Titagarh Rail Systems:
Kolkata-based Titagarh Rail Systems has secured a Letter of Acceptance from Banaras Locomotive Works for the complete shell assembly of WAG-9HC locomotives. The order, valued at ₹91.12 crore (including GST), strengthens Titagarh’s position in India’s fast-growing railway manufacturing sector.
Also Read: Market Rally Unveils Big Winners – 8 Stocks at Their Strongest Levels in a Year
- Brigade Enterprises:
Bengaluru-based Brigade Enterprises launched “Brigade Lakecrest”, a premium residential project near Bhattarahalli Lake on Old Madras Road. Developed under a joint development model, the project spans 9.33 lakh sq. ft. and is expected to generate revenues exceeding ₹950 crore.
- IDBI Bank:
IDBI Bank announced that SEBI has approved the reclassification of Life Insurance Corporation of India (LIC) as a public shareholder rather than a promoter. This move is subject to specific conditions and is a significant step in IDBI’s transition towards privatization.
- RailTel Corporation of India:
RailTel has received a work order worth ₹13.16 crore (including taxes) from the Rajasthan Skill & Livelihoods Development Corporation (RSLDC) to provide project management consultancy (PMC) services.
- Interarch Building Solutions:
Interarch Building Solutions secured a ₹90 crore order from Rungta Mines Limited for designing, engineering, manufacturing, and erecting a pre-engineered steel building system.
- IndusInd Bank:
IndusInd Bank saw its credit rating affirmed at CRISIL AA+ with a Negative outlook by CRISIL Ratings, while also being removed from the “watch with negative implications” list.
- Akums Drugs and Pharmaceuticals:
Akums Drugs signed a Framework Agreement with the Government of the Republic of Zambia on August 22, 2025, to establish a local pharmaceutical manufacturing facility. The project aims to support Zambia’s national healthcare programs while boosting local production capacity.
- Eris Lifesciences:
Eris Lifesciences disclosed that it has received a show cause-cum-demand notice from the Directorate General of GST Intelligence (DGGI), Mumbai, regarding alleged non-payment of IGST under the reverse charge mechanism for import of services.
READ MORE ON
